UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 


 

Date of Report (Date of earliest event reported): September 13, 2013 (September 10, 2013)

 

LIFEPOINT HOSPITALS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-51251

 

20-1538254

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

103 Powell Court

Brentwood, Tennessee

 

37027

(Address of principal executive offices)

 

(Zip Code)

 

(615) 372-8500

(Registrant’s telephone number, including area code)

 

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Explanatory Note

 

LifePoint Hospitals, Inc. (the “Company”) is filing this amended Current Report on Form 8-K/A as an Amendment to its Current Report on Form 8-K filed on August 21, 2013 to disclose Mr. Murphy’s compensation as Chief Financial Officer.  No other information contained in the Form 8-K is amended by this Form 8-K/A.

 

Item 5.02.                Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

In connection with Mr. Murphy’s appointment as Chief Financial Officer, on September 10, 2013 at a regularly scheduled meeting, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) increased Mr. Murphy’s base salary to $525,000, granted Mr. Murphy 35,000 non-qualified stock options with an exercise price of $45.41 and awarded Mr. Murphy 15,000 restricted stock units (which will, upon vesting, entitle Mr. Murphy to receive one share of the Common Stock of the Company for each restricted stock unit).  The non-qualified stock options vest in three equal installments beginning on the first anniversary of the date of grant.  The restricted stock units vest only if Mr. Murphy remains employed by the Company on the third anniversary of the date of grant and the achievement by the Company of financial targets set by the Compensation Committee.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

LIFEPOINT HOSPITALS, INC.

 

 

 

 

 

By:

/s/ Paul D. Gilbert

 

Name:

Paul D. Gilbert

 

Title:

Executive Vice President and Chief Legal Officer

 

 

Date: September 13, 2013

 

3